New Cryopreserved Human Primary Cell Lines Now Available

SeraCare attests that these products are highly pure primary cells with greater than 90% viability.

“The availability of large lots from the same donor provides a significant advantage for investigators, especially those performing longitudinal studies, as it greatly reduces study variability and facilitates consistency and reproducibility,” said Tina Patel, associate technical product manager at SeraCare Life Sciences. “SeraCare’s extensive sourcing network and donor program also enables the company to potentially contact the same donors for additional draws.”

In addition to the “off-the-shelf” Cryo-M and Cryo-T4 Human PBMC subsets, which include a broad range of donor demographics and related HLA information, SeraCare can provide cryopreserved cells customized to individual customer needs including disease-specific, allergen-specific, and genotype-specific options.

Related Links:
SeraCare Life Sciences